Washington Post Tracks Escalating Fight Over GLP-1 Coverage
Health Brief examines disputes among payers, employers and policymakers over who pays for costly obesity drugs.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 17 00:44 ETSource: The Washington Post
The wire
- 01Washington Post Health Brief covered the ongoing battle over insurance coverage of GLP-1 drugs.
- 02Coverage decisions determine patient access and manufacturer revenue at scale.
- 03Specific policy proposals and payer decisions were not detailed in the excerpt.
From the source
Read at news.google.comHealth Brief: The fight over GLP-1 coverage